Related Experiment Videos
Interactions between detoxifying enzyme polymorphisms and susceptibility to cancer
1Clinical Biochemistry Research Group, Centre for Cell and Molecular Medicine, University of Keele, North Staffordshire Hospital, Stoke-on-Trent, United Kingdom.
IARC Scientific Publications
|September 24, 1999
Summary
Investigating gene interactions in cancer risk requires studying combinations of detoxifying enzyme polymorphisms. Current research highlights the need for robust statistical methods to identify clinically significant genetic interactions.
Area of Science:
- Pharmacogenomics and Cancer Epidemiology
- Genetic Toxicology and Carcinogenesis
- Biomarker Discovery in Oncology
Background:
- Case-control studies often show modest associations between single detoxifying enzyme polymorphisms and cancer susceptibility (odds ratios of 2-3).
- Combinations of risk alleles are increasingly studied to identify high-impact haplotypes (odds ratio > 15) for clinical relevance.
- Interactions between detoxifying enzyme genes are biologically plausible, involving sequential detoxification pathways, overlapping substrates, or coordinated gene expression.
Purpose of the Study:
- To explore the rationale and statistical approaches for studying interactions between detoxifying enzyme gene polymorphisms in cancer risk.
- To critically evaluate existing evidence, particularly the combined effects of GSTM1 null and CYP1A1 rare alleles in lung cancer.
- To emphasize the need for novel statistical methods and clinically significant angles in genetic association studies.
Main Methods:
- Review of existing literature on detoxifying enzyme polymorphisms and cancer susceptibility.
- Discussion of biological mechanisms underlying gene-gene interactions in xenobiotic metabolism.
- Introduction to statistical approaches for assessing gene-gene interactions, including subgroup analysis.
Main Results:
- Accumulating evidence suggests a significant increased risk for lung cancer with combined GSTM1 null/CYP1A1 rare alleles, especially in smokers.
- Debate exists regarding the functional impact of certain polymorphisms (e.g., CYP1A1, CYP2D6), questioning whether they are causal or linkage markers.
- A comparative lack of robust data supporting synergism between various detoxifying enzyme gene interactions.
Conclusions:
- Studying combinations of risk alleles and gene-gene interactions is crucial for identifying clinically significant cancer risk factors.
- The functional relevance of certain investigated polymorphisms needs further validation.
- Future research should employ advanced statistical methods to uncover novel, clinically significant genetic interactions, likely involving multiple genes.